News: Portfolio

Quartet closes an upsized A round with a novel approach to pain

MGH spinout and PIF portfolio company, Quartet Medicine, added $6.25 million to its Series A fundraise, closing the round at $23.25 million as it moves toward clinical trials with a newfangled way of treating chronic pain.

Get the full story here